CEACAM5 and cancer: The following variables were associated with poorer cancer‐specific survival on univariate analysis (Table 3): largest metastasis size >50 mm, number of liver metastases >1, preoperative CEA >200 ng/mL, presence of bilobar disease, performance of major hepatectomy, positive (R1) microscopic margin, concomitant resection of extrahepatic disease, perioperative blood transfusion, and absence of repeat hepatectomy.